Focal segmental glomerulosclerosis is associated with a PDSS2 haplotype and, independently, with a decreased content of coenzyme Q10.
about
Mitochondrial dysfunction in inherited renal disease and acute kidney injuryDefining nephrotic syndrome from an integrative genomics perspective.The podocyte power-plant disaster and its contribution to glomerulopathy.Resveratrol and para-coumarate serve as ring precursors for coenzyme Q biosynthesis.Mitochondrial and cytoskeletal alterations are involved in the pathogenesis of hydronephrosis in ICR/Mlac-hydro miceThe Genetics of Nephrotic Syndrome.Coenzyme Q supplementation or over-expression of the yeast Coq8 putative kinase stabilizes multi-subunit Coq polypeptide complexes in yeast coq null mutants.Renal manifestations of genetic mitochondrial disease.Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency.Molecular diagnosis of coenzyme Q10 deficiency.Focal Segmental Glomerulosclerosis.Rescue of primary ubiquinone deficiency due to a novel COQ7 defect using 2,4-dihydroxybensoic acid.Increasing the level of peroxisome proliferator-activated receptor γ coactivator-1α in podocytes results in collapsing glomerulopathy.Osmotic stress: Is CoQ a membrane stabilizer?A Personalized Model of COQ2 Nephropathy Rescued by the Wild-Type COQ2 Allele or Dietary Coenzyme Q10 Supplementation.Coenzyme Q10 supplementation therapy for 2 children with proteinuria renal disease and ADCK4 mutation: Case reports and literature review.Diffuse mesangial sclerosis in a PDSS2 mutation-induced coenzyme Q10 deficiency.Biochemistry of Mitochondrial Coenzyme Q Biosynthesis.Oxidative Stress, Apoptosis, and Mitochondrial Function in Diabetic Nephropathy.
P2860
Q33793389-21DB9E0D-E3E4-401C-9290-59A84A22321CQ34560989-1E6FEC73-5BF5-40BC-827A-E4FA89293966Q34699773-299025FB-C0B6-4677-93DC-8DC9077894EDQ35217058-8D2BE5D3-2349-462F-9B9B-9CBC8BD5F530Q35958998-52689807-0B79-4032-AFEE-DF12BE52F41DQ37032671-2E89F7F1-F197-4C67-8D94-019BEF7FB66AQ37647874-B4D90209-6184-43AD-99E4-D104AD0E48B7Q38187116-6F31FE8C-32B5-4DBC-A015-C4CEF4F3A2D6Q38236847-D82E479C-66A1-428D-94E8-5B0D6EE97153Q38542981-0F9B8D3C-E92F-458F-B48E-87994227EB72Q38938623-5C4DBE9C-A07A-4037-BA4D-5022E7EE0EA1Q40826733-56C48CA3-F22B-4E18-84AC-57170106827AQ41068117-35FF589D-8C57-45A1-BC1A-6BC162AE1D8DQ46256631-458FA3DE-3FCA-4FE0-9011-C0B31D8792D1Q46379802-774FE558-8BE7-44E5-A73F-666B8FD23FACQ47134250-6CB13955-AEA0-4894-8237-5325F2337352Q47649929-2D688E7A-2DBC-4198-A42E-E885C9BA1C25Q47777099-F919258A-84D3-43E8-9280-4A3F94CCCB45Q54977897-761AFF5E-C31C-441C-A33B-E32ACCDAC33B
P2860
Focal segmental glomerulosclerosis is associated with a PDSS2 haplotype and, independently, with a decreased content of coenzyme Q10.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Focal segmental glomeruloscler ...... eased content of coenzyme Q10.
@en
Focal segmental glomeruloscler ...... eased content of coenzyme Q10.
@nl
type
label
Focal segmental glomeruloscler ...... eased content of coenzyme Q10.
@en
Focal segmental glomeruloscler ...... eased content of coenzyme Q10.
@nl
prefLabel
Focal segmental glomeruloscler ...... eased content of coenzyme Q10.
@en
Focal segmental glomeruloscler ...... eased content of coenzyme Q10.
@nl
P2093
P2860
P1476
Focal segmental glomeruloscler ...... eased content of coenzyme Q10.
@en
P2093
Beth N Marbois
Catherine F Clarke
Cheryl A Winkler
David L Gasser
Gregory D Kirk
Letian X Xie
Louise M McKenzie
Yuchen Shi
P2860
P304
P356
10.1152/AJPRENAL.00143.2013
P577
2013-08-07T00:00:00Z